Voyageur secures exclusive rights to rare pharmaceutical mineral

The technology to extract C-60 from natural fullerene deposits is ground-breaking and a first in this industry, said the company

Calgary-based Voyageur Pharmaceuticals Ltd. says it has signed an Letter of Intent with an established international mining company that has developed a low cost method to extract the natural occurring carbon molecule, C-60 to C-90, from  large natural-occurring fullerene resources.

The technology to extract C-60 from natural fullerene deposits is ground-breaking and a first in this industry, it said in a news release.

“Voyageur will be the first company to be able to mass produce C-60 at a low cost, allowing for multiple drug products to be developed,” said Brent Willis, CEO of Voyageur Pharmaceuticals

“The barriers for C-60 based drugs has now been broken, which opens up the industry to develop new effective drugs and health care products on an economic scale.”

Voyageur said the API, C-60, is a natural, highly effective super antioxidant, like more common antioxidants (Vitamin C, Vitamin A and Selenium). It scavenges toxic free radicals but it stands out as a notable anti-aging innovation because it selectively scavenges the reactive oxygen species that do the most damage to humans as opposed to just working by osmosis like a normal antioxidant. .

Voyageur said it has begun work on its first C-60 product, C-60X, an immune system booster, natural health product, for daily consumption. Voyageur is creating a C-60 Research & Development Therapeutics division that will be focused on developing natural health products and drugs.

 

You must be logged in to post a comment Login